Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-006770
Filing Date
2015-01-27
Accepted
2015-01-27 16:15:07
Documents
1
Period of Report
2015-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5897
  Complete submission text file 0001209191-15-006770.txt   7189
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Kanes Stephen (Reporting) CIK: 0001612859 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 15551934